Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.04 – $0.12
18% from low
Exchange
OTC Link
CS
Borrow rate
0.33%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $826.7K | $1.2M | $653.5K | $4.4M | $4.7M |
| Cost of revenue | $616 | $0 | $0 | $731.3K | $1.1M | $467.5K | $3.5M | $3.6M |
| Gross profit | −$616 | $0 | $0 | $95.5K | $18.9K | $186.0K | $835.1K | $1.1M |
| Gross margin | — | — | — | 11.5% | 1.6% | 28.5% | 19.2% | 23.9% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$47.7K | −$40.8K | −$27.4K | −$757.3K | −$29.3M | −$3.6M | −$4.0M | −$3.2M |
| EBITDA | −$47.1K | −$40.8K | $0 | −$756.9K | −$29.3M | −$3.6M | −$3.9M | −$3.0M |
| Net income | −$47.7K | −$40.8K | −$27.4K | −$757.3K | −$29.6M | −$4.0M | −$4.9M | −$4.3M |
| Net margin | — | — | — | -91.6% | -2544.7% | -617.5% | -113.4% | -91.4% |
| EPS (diluted) | -0.00 | -0.00 | -0.00 | -0.08 | -1.35 | -0.12 | -0.11 | -0.07 |
Annual figures · source: Financial Modeling Prep
GPO PLUS INC
No one on the platform currently holds GPOX.
No tracked institution reports a position in GPOX as of their last filing.
No one on the platform has traded GPOX yet.
| $5M |
| — |
| PRACProductivity Technologies Corp. | $0.14 | +0.00% | $576975 | — |
| QINDQuality Industrial Corp. | $0.01 | +3.00% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 0.5× sales vs its 4.5× historical median P/S.
Fair value ≈ $0.49 · price $0.06 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Retail growth usually comes down to execution: distribution, relationships, and scale. That’s the part many investors overlook. $GPOX
View on StockTwits ↗One thing we’ve learned in $GPOX distribution: consistency at the store level matters more than scale alone. Weekly execution, inventory visibility, and route efficiency can have a meaningful impact across independent retail networks. https://gpoplus.com/memo/
View on StockTwits ↗We published our full investor memorandum last Friday Three years of operating work, audited financials, the full story of what we built and what we learned. The most honest account we know how to write. Read it for yourself: GPOPlus.com/investor-memo Three years ago: 500 stores, $180 per store per month, 15% margin. Today: same stores, roughly $1,000 per store per month, 28% margin. Six times the revenue. Thirteen points of margin expansion. The work was real. I will be on here answering substantive questions. Bring them. $GPOX
View on StockTwits ↗GPO Plus $GPOX look like they are steadily improving but it seems like there is still a lot of room for improvement From their last earnings statement revenue had came up 9% year over year to 4.7 million This shows progress but not enough to call it a full blow turnaround Losses are still dollar to dollar with total revenue so closing that gap would take continued innovation and pressure on the cost side What do you guys think though ? Below I posted a picture of their last income statement
View on StockTwits ↗$GPOX is disrupting the $1.5T digital health + distribution market Key Highlights: • 6x revenue growth • 20% sequential quarterly growth • PRISM+ AI platform scaling DSD • Gross margins rising • Expanding into the $327B c-store market Positives: • Strong momentum • Growing visibility • AI + logistics narrative gaining traction GPOX remains a speculative high-growth small-cap to watch. Communicated Disclaimer - https://stockresearchtoday.com/gopx/ Other movers: $POET $AKAN $AGPU $ELPW
View on StockTwits ↗$GPOX GPOX is a speculative "penny stock" with significant fundamental red flags, including negative book value and a high burn rate. While revenue is growing, the heavy debt load and "going concern" status suggest a high risk of total loss unless they can achieve a rapid path to profitability or secure massive non-dilutive capital.
View on StockTwits ↗$GPOX is disrupting the $1.5T digital health and distribution space by integrating AI-driven logistics with telemedicine and Rx delivery. Key Highlights: • 6x revenue growth (3 yrs) • 20% sequential quarterly growth • Proprietary PRISM+ AI platform optimizing DSD • National ad campaign live as of April 2026 By modernizing retail distribution for the $327B+ c-store market, $GPOX is a high-growth play to watch. Communicated Disclaimer - https://stockresearchtoday.com/gopx/ Other stocks moving today: $POET $AKAN $AGPU $ELPW
View on StockTwits ↗$GPOX is a small cap distribution company going after the massive convenience store and gas station market with a more modern approach. Instead of relying on layers of middlemen, they focus on getting products directly into stores faster and more efficiently. What makes it interesting is the scalability. The model is built to expand across a large number of locations, with technology helping manage inventory, logistics, and sales as it grows. As more stores get added, the system becomes more efficient rather than more complicated. It is still early, but the company has started to show signs of expansion through new locations, product rollout, and improving operations. If they continue executing, there is room to grow into a much larger presence in a very fragmented industry. Communicated-disclaimer: https://stockresearchtoday.com/gopx/
View on StockTwits ↗$GPOX : A Scalable Digital Health Platform Gaining National Traction 💊 Beyond its pharmacy platform, the company operates a direct store delivery model, generating recurring revenue and strong retailer relationships. 📊 Recent Momentum & Milestones ◆ Strategic partnerships expanding distribution reach ◆ First national ad campaign targeting chain level customers and scaling brand awareness ◆ 6× revenue growth over the past 3 years, supporting continued national expansion 🧠 Platform & Strategy ◆ Proprietary tech stack for inventory, logistics, and data-driven operations ◆ Hybrid B2B + DTC model across distribution and consumer services ◆ Targeting fragmented retail markets with consolidation potential Positioned at the intersection of tech, pharma, and convenience, GPOX is targeting a $900B+ digital health market and a $600B+ U.S. pharmacy sector. Communicated Disclaimer: https://stockresearchtoday.com/gopx/ Sector peers: $HIMS $LFMD $TDOC $AMWL
View on StockTwits ↗Is $GPOX the Most Underrated AI Stock Right Now? GPO Plus is an AI-powered Direct Store Delivery company modernizing distribution to gas stations & convenience stores via their proprietary PRISM+ platform. 📰 Latest News: • Apr 2026 — Launched first national digital ad campaign targeting regional c-store chain operators • Apr 2026 — Attended NACS State of the Industry Summit to sharpen merchandising strategy • Jan 2026 — CEO presented at Sequire Investor Summit, showcasing growth & DSD expansion 📈 Key Numbers: • 6x revenue growth in 2.5 years • 20% sequential quarterly revenue growth • 23.8% gross margin on $4.7M TTM revenue • $327B+ addressable market Quietly building. Nationally expanding. $GPOX is one to watch. CommunicatedDisclaimer: http://stockresearchtoday.com/gopx/
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.